Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep:62:101124.
doi: 10.1016/j.arr.2020.101124. Epub 2020 Jul 16.

Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality

Affiliations
Review

Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality

Yangyang Cheng et al. Ageing Res Rev. 2020 Sep.

Abstract

Background: Influenza vaccination is a simple strategy recommended for the prevention of influenza infection and its complications. This meta-analysis aimed to provide current supportive evidence for the breadth and validity of the observed protective effects of influenza vaccination on cardiovascular and respiratory adverse outcomes and all-cause mortality in older adults and in general adult population.

Methods: We searched PubMed, Embase, Web of Science, and the Cochrane Library to identify all published studies comparing influenza vaccination with placebo from the database inception to November 11, 2018. These included studies reporting the associations of influenza vaccination with the risk of aforementioned adverse outcomes.

Results: The pooled adjusted relative risks among influenza-vaccinated people relative to unvaccinated people for the outcomes of interest were 0.74 (95 % confidence interval [CI] = 0.70-0.78) for cardiovascular diseases (63 studies), 0.82 (95 % CI = 0.75-0.91) for respiratory diseases (29 studies), and 0.57 (95 % CI = 0.51-0.63) for all-cause mortality (43 studies). We performed subgroup analysis of age, sex, and region/country and found that these protective effects were evident in the general adult population and particularly robust in older adults and in those with pre-existing specific diseases.

Conclusion: Influenza vaccine is associated with a significant risk reduction of cardiovascular and respiratory adverse outcomes as well as all-cause mortality. Such a preventative measure can benefit the general population as well as those in old age and with pre-existing specific diseases.

Keywords: All-cause mortality; Cardiovascular disease; Influenza vaccination; Respiratory disease.

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Figures

Fig. 1
Fig. 1
Details of study selection for meta-analysis.
Fig. 2
Fig. 2
Forest plot of incident cardiovascular diseases associated with influenza vaccination.
Fig. 3
Fig. 3
Forest plot of incident respiratory diseases associated with influenza vaccination.
Fig. 4
Fig. 4
Forest plot of all-cause mortality associated with influenza vaccination.

References

    1. Armstrong B.G., Mangtani P., Fletcher A., Kovats S., McMichael A., Pattenden S., Wilkinson P. Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ. 2004;329:660. - PMC - PubMed
    1. Arriola C., Garg S., Anderson E.J., Ryan P.A., George A., Zansky S.M., Bennett N., Reingold A., Bargsten M., Miller L., Yousey-Hindes K., Tatham L., Bohm S.R., Lynfield R., Thomas A., Lindegren M.L., Schaffner W., Fry A.M., Chaves S.S. Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza. Clin. Infect. Dis. 2017;65:1289–1297. - PMC - PubMed
    1. Barnett R. Acute myocardial infarction. Lancet (London, England) 2019;393:2580. - PubMed
    1. Blaya-Nováková V., Prado-Galbarro F.J., Sarría-Santamera A. Effects of annual influenza vaccination on mortality in patients with heart failure. Eur. J. Public Health. 2016;26:890–892. - PubMed
    1. Bonafè M., Prattichizzo F., Giuliani A., Storci G., Sabbatinelli J., Olivieri F. Inflamm-aging: why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev. 2020;53:33–37. - PMC - PubMed

Publication types

MeSH terms

Substances